WanzerSH, FedermanDD, AdelsteinSJ, The physician's responsibility toward hopelessly ill patients — a second look. N Engl J Med1989; 120: 844–849.
2.
SmithRS. Ethical issues in cancer pain. In: ChapmanCR, FoleyKM (eds). Current and Emerging Issues in Cancer Pain: Research and Practice.New York: Raven Press, 1993; 385–392.
3.
RoyDJ. Need they sleep before they die?J Palliat Care1991; 6(3): 3–4.
4.
LatimerE.Ethical challenges in cancer care. J Palliat Care1992; 8(1): 65–70.
5.
PollardBJ. Dying: rights and responsibilities. Med J Aust1988; 149(3): 147–149.
6.
ScanlonC, FlemingC.Ethical issues in caring for the patient with advanced cancer. Nurs Clin North Am1989; 24(4): 977–986.
7.
President's Commission for the Study of Ethical Problems in Medical and Biomedical and Behavioral Research. Deciding to Forgo Life Sustaining Treatment: Ethical and Legal Issues in Treatment Decisions. Washington: U.S. Government Printing Office, 1983.
8.
American Medical Association Council on Ethical and Judicial Affairs.Decisions near the end of life. JAMA1992; 267: 2229–2233.
9.
American College of Physicians Health and Public Policy Committee.Drug therapy for severe chronic pain in terminal illness. Ann Intern Med1983; 99: 870–880.
10.
American Pain Society.Principles of Analgesic Use in the Treatment of Acute Pain and Chronic Cancer Pain. A Concise Guide to Medical Practice, 3rd ed. Skokie, Illinois: American Pain Society, 1992.
11.
World Health Organization.Cancer Pain Relief and Palliative Care. Geneva: World Health Organization, 1990.
12.
American Pain Society Committee of Quality Assurance Standards.American Pain Society quality assurance standards for the relief of acute pain and cancer pain. In: BondMR, CharltonJE, WoolfCJ (eds). Proceedings of the VIth World Congress on Pain. Amsterdam: Elsevier, 1991: 185–190. Pain Research and Clinical Management; vol. 4.
13.
SprossJA, McGuireDB, SchmittRM. Oncology Nursing Society Position Paper on Cancer Pain. Part I. Oncol Nurs Forum1990; 17(4): 595–614.
14.
SprossJA, McGuireDB, SchmittRM. Oncology Nursing Society Position Paper on Cancer Pain. Part II. Oncol Nurs Forum1990; 17(5): 751–760.
15.
American College of Physicians Ethics Committee.American College of Physicians Ethics Manual, 3rd ed. Ann Intern Med1992; 117: 947–960.
16.
EnckRE. Drug-induced terminal sedation for symptom control. Am J Hosp Palliat Care1991; 8(5): 3–5.
17.
VentafriddaV, RipamontiC, De ConnoF, TamburiniM, CassilethBR. Symptom prevalence and control during cancer patients’ last days of life. J Palliat Care1990; 6(3): 7–11.
18.
MountB.A final crescendo of pain. J Palliat Care1990; 6(3): 5–6.
19.
FainsingerR, MillerMJ, BrueraE, HansonJ, MaceachernT.Symptom control during the last week of life on a palliative care unit. J Palliat Care1991; 7(1): 5–11.
20.
HigginsonI, McCarthyM.Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?J R Soc Med1989; 82(5): 264–267.
21.
LichterI, HuntE.The last 48 hours of life. J Palliat Care1990; 6(4): 7–15.
22.
MorrisJN, MorV, GoldbergRJ, SherwoodS, GreerDS, HirisJ.The effect of treatment setting and patient characteristics on pain in terminal cancer patients: a report from the national hospice setting. J Chron Dis1986; 39(1): 27–35.
23.
ReubenDB, MorV.Dyspnea in terminally ill cancer patients. Chest1986; 89(2): 234–236.
24.
PortenoyRK, MoulinDE, RogersA, InturrisiCE, FoleyKM. IV infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treatment Reports1986; 70(5): 575–581.
25.
Von RoennJH, CleelandCS, GoninR, HatfieldA, PandyaKJ. Physician's attitudes and practice in cancer pain management: A survey from the Eastern Cooperative Oncology Group. Ann Intern Med1993; 119(2): 121–126.
26.
GonzalesGR, ElliotKJ, PortenoyRK, FoleyKM. The impact of a comprehensive evaluation in the management of cancer pain. Pain1991; 47:141–144.
27.
CoyleN, BreitbartW, WeaverS, PortenoyRK. Delirium as a contributing factor to “crescendo” pain: three case reports. J Pain Sympt Manage1994; 9(1): 44–47.
28.
BreitbartW, PassikSD. Psychiatric aspects of palliative care. In: DoyleD, HanksGW, MacDonaldN (eds). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993; 609–626.
29.
DoyleD.Have we looked beyond the physical and psychosocial?J Pain Sympt Manage1992; 7(5): 302–311.
30.
MobergDO, BrusekPM. Spiritual well-being: a neglected subject in quality of life research. Social Indicators Research1978; 5: 303–323.
31.
International Work Group For Death and Dying.Assumptions and principles of spiritual care. Death Studies1990; 14: 75–81.
32.
SpeckPW. Spiritual issues in palliative care. In: DoyleD, HanksGW, MacDonaldN (eds). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993; 517–525.
33.
YalomID. Existential Psychotherapy. New York: Basic Books, 1980.
34.
Scanlon C. Creating a vision of hope: the challenge of palliative care. Oncol Nurs Forum1989; 16(4): 491–496.
35.
ChernyNI, PortenoyRK. Practical issues in the management of cancer pain. In: WallPD, MelzackR (eds). Textbook of Pain, 3rd ed. Edinburgh: Churchill Livingstone, 1994; 1437–1467.
36.
HainesIE, ZalcbergJ, BuchananJD. Not-for-resuscitation orders in cancer patients: principles of decision making. Med J Aust1990; 153(7): 225–229.
37.
RosnerF, KarkPR, BennettAJ, Medical futility. Committee on Bioethical Issues of the Medical Society of the State of New York. NY State J Med1992; 92(11): 485–488.
38.
DunlopRJ. Excitatory phenomena associated with high dose opioids. Curr Ther1989; 30(6): 121–123.
39.
AmesburyBDW. Use of SC midazolam in the home care setting. Palliat Med1989; 3: 299–301.
40.
BurkeAL, DiamondPL, HulbertJ, YeatmanJ, FarrEA. Terminal restlessness — its management and the role of midazolam. Med J Aust1991; 155(7): 485–487.
41.
JohansonGA. Midazolam in terminal care. Am J Hosp Palliat Care1993; 10(1): 13–14.
42.
EnckRE. The last few days. Am J Hosp Palliat Care1992; 9(4): 11–13.
43.
McNamaraP, MintonP, TwycrossRG. The use of midazolam in palliative care. Palliat Med1991; 5: 244–249.
TwycrossRG, LichterI.The terminal phase. In: DoyleD, HanksGW, MacDonaldN (eds). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993; 651–661.
47.
GustersonFR, KayJ, KingsburyAW. Analgesia in terminal malignant disease [letter]. Br Med J1979; 2(6181).
48.
OliverOJ. The use of methotrimeprazine in terminal care. Br J Clin Pract1985; 39: 339–340.
49.
McGiverB, WalshD, NelsonK.The use of chlorpromazine for symptom control in the dying cancer patient. J Pain Sympt Manage1994; in press.
50.
GreeneWR, DavisWH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J1991; 84(3): 332–337.
51.
TruogRD, BerdeCB, MitchellC, GreirHE. Barbiturates in the care of the terminally ill. N Engl J Med1992; 327(23): 1678–1682.
52.
CoyleN, AdelhardtJ, FoleyKM, PortenoyRK. Character of terminal illness in the advanced cancer patient: pain and other symptoms during last four weeks of life. J Pain Sympt Manage1990; 5: 83–89.
53.
EdwardsRB. Pain management and the values of health care providers. In: HillCS, FieldsWS (eds). Drug Treatment of Cancer Pain in a Drug Oriented Society. New York: Raven Press, 1989; 101–112. Advances in Pain Research and Therapy; vol. 11.
54.
MartinRS. Mortal values: healing, pain and suffering. In: HillCS, FieldsWS (eds). Drug Treatment of Cancer Pain in a Drug Oriented Society. New York: Raven Press, 1989: 19–26. Advances in Pain Research and Therapy; vol. 11.
55.
LatimerEJ. Ethical decision-making in the care of the dying and its applications to clinical practice. J Pain Sympt Manage1991; 6: 329–336.
56.
QuillTE. The ambiguity of clinical intentions. N Engl J Med1993; 329: 1039–1040.